About the Division of Pharmacologic Therapies (DPT)

Learn how SAMHSA’s Division of Pharmacologic Therapies (DPT) works to oversee medication-assisted treatment (MAT) for substance use disorders.

The Division of Pharmacologic Therapies (DPT), part of the SAMHSA Center for Substance Abuse Treatment (CSAT), manages the day-to-day oversight activities necessary to implement federal regulations on the use of substance use disorder medications such as methadone and buprenorphine. These activities include supporting the accreditation and certification of more than 1,250 opioid treatment programs (OTPs) that collectively treat more than 300,000 patients each year. Learn more about SAMHSA’s certification of OTPs and oversight of OTP Accrediting Bodies.

DPT also implements the Drug Addiction Treatment Act of 2000 (DATA 2000). This law expands the clinical context of medication-assisted treatment (MAT) by allowing qualified physicians to dispense or prescribe medications for the treatment of opioid addiction in settings other than OTPs and other facilities.

Learn about the different medications used in MAT approved by the Food and Drug Administration (FDA) to treat substance use disorders.

Learn more about the legislation, regulations, and guidelines that govern MAT.

Other SAMHSA Efforts

SAMHSA provides grants and technical assistance at the community level aimed at expanding or enhancing MAT and other clinically-appropriate services for people with these disorders. SAMHSA targets its funding efforts at states with the highest rates of admissions for the treatment of opioid use disorders, prioritizing grants that improve existing treatment service systems and recovery support services.

It is important that patients in MAT receive uninterrupted treatment and services. In order to improve access and help ensure continuity of care for patients in OTPs, SAMHSA developed the Service Continuity Pilot (SCP) project. The pilot project, part of SAMHSA’s larger efforts to advance the use of health information technology, will allow patient dosing information to be exchanged between OTPs through health information exchanges. On May 1, 2015, SAMHSA launched the SCP project with a health information exchange based in South Bend, Indiana. Access the OTP SCP Contract Funding Opportunity (PDF | 440 KB) announcement to learn more.

SAMHSA also has a number of continuing grants and contracts that support the regulatory oversight and monitoring activities of OTPs. Access SAMHSA Budget Fiscal Year 2016 documents to learn more about SAMHSA grants and other funding efforts in support of expanding MAT.

Additionally, SAMHSA provides MAT professionals with:

Learn more about medication and counseling treatment.

Last Updated: 01/19/2018